新的亚变种是免疫逃避的高手。

New subvariants are masters of immune evasion.

出版信息

Science. 2022 May 13;376(6594):679-680. doi: 10.1126/science.adc9448. Epub 2022 May 12.

DOI:10.1126/science.adc9448

PMID:35549399

Abstract

Vaccines and prior infection still prevent severe disease from new SARS-CoV-2 strains.

摘要

疫苗和既往感染仍能预防新的 SARS-CoV-2 变异株引起的重症疾病。

相似文献

New subvariants are masters of immune evasion.

Science. 2022 May 13;376(6594):679-680. doi: 10.1126/science.adc9448. Epub 2022 May 12.

[Immune memory against SARS-CoV-2: Antibodies against the initial infection and memory B cells for the future ones].

Med Sci (Paris). 2021 Aug-Sep;37(8-9):722-725. doi: 10.1051/medsci/2021122. Epub 2021 Aug 4.

New Omicron strains may portend big COVID-19 waves.

Science. 2022 Sep 30;377(6614):1479. doi: 10.1126/science.adf0777. Epub 2022 Sep 29.

Could new COVID variants undermine vaccines? Labs scramble to find out.

Nature. 2021 Jan;589(7841):177-178. doi: 10.1038/d41586-021-00031-0.

Coronavirus variants are spreading in India - what scientists know so far.

Nature. 2021 May;593(7859):321-322. doi: 10.1038/d41586-021-01274-7.

Pfizer COVID vaccine protects against worrying coronavirus variants.

Nature. 2021 May;593(7859):325-326. doi: 10.1038/d41586-021-01222-5.

Why COVID vaccines are so difficult to compare.

Nature. 2021 Mar;591(7848):16-17. doi: 10.1038/d41586-021-00409-0.

COVID-19 vaccine breakthrough infections.

Science. 2021 Dec 24;374(6575):1561-1562. doi: 10.1126/science.abl8487. Epub 2021 Dec 23.

Omicron likely to weaken COVID vaccine protection.

Nature. 2021 Dec;600(7889):367-368. doi: 10.1038/d41586-021-03672-3.

Metabolic disorders, COVID-19 and vaccine-breakthrough infections.

Nat Rev Endocrinol. 2022 Feb;18(2):75-76. doi: 10.1038/s41574-021-00608-9.

引用本文的文献

γδ T cells: origin and fate, subsets, diseases and immunotherapy.

Signal Transduct Target Ther. 2023 Nov 22;8(1):434. doi: 10.1038/s41392-023-01653-8.

A critical analysis of the current state of virus taxonomy.

Front Microbiol. 2023 Aug 3;14:1240993. doi: 10.3389/fmicb.2023.1240993. eCollection 2023.

Increased vaccine sensitivity of an emerging SARS-CoV-2 variant.

Nat Commun. 2023 Jun 29;14(1):3854. doi: 10.1038/s41467-023-39567-2.

Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches.

Mol Immunol. 2023 Apr;156:10-19. doi: 10.1016/j.molimm.2022.11.020. Epub 2022 Nov 24.

Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation.

Front Immunol. 2023 Feb 10;14:1114396. doi: 10.3389/fimmu.2023.1114396. eCollection 2023.

Selective sweeps in SARS-CoV-2 variant competition.

Proc Natl Acad Sci U S A. 2022 Nov 22;119(47):e2213879119. doi: 10.1073/pnas.2213879119. Epub 2022 Nov 3.

Developing evolution-resistant drugs for COVID-19.

Elife. 2022 Jul 26;11:e81334. doi: 10.7554/eLife.81334.

Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.

Signal Transduct Target Ther. 2022 Jul 19;7(1):241. doi: 10.1038/s41392-022-01105-9.

Renaming the SARS-CoV-2 Omicron sublineages as SARS-CoV-3 is contrary to nomenclature standards based on evolutionary and serological evidence.

Clin Transl Med. 2022 Jun;12(6):e924. doi: 10.1002/ctm2.924.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

新的亚变种是免疫逃避的高手。

New subvariants are masters of immune evasion.

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献